Literature DB >> 14678036

CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential.

Shuang Fu1, Adam C Yopp, Xia Mao, Dongmei Chen, Nan Zhang, Dan Chen, Minwei Mao, Yaozhong Ding, Jonathan S Bromberg.   

Abstract

CD4+ CD25+ regulatory T cells (Treg) are potent suppressors, and play important roles in autoimmunity and transplantation. Recent reports suggest that CD4+ CD25+ Treg are not a homogeneous cell population, but the differences in phenotype, function, and mechanisms among different subsets are unknown. Here, we demonstrate CD4+ CD25+ Treg cells can be divided into subsets according to cell-surface expression of CD62L. While both subsets express foxp3 and are anergic, the CD62L+ population is more potent on a per cell basis, and proliferates and maintains suppressive function far better than the CD62L- population and unseparated CD4+ CD25+ Treg. The CD62L+ population preferentially migrates to CCL19, MCP-1 and FTY720. Both CD62L+ and CD62L- subsets prevent the development of autoimmune gastritis and colitis induced by CD4+ CD25-CD45RBhigh cells in severe combined immunodeficiency (SCID) mice. Overall, these results suggest CD4+ CD25+ Treg are not a homogenous cell population, but can be divided into at least two subsets according to CD62L expression. The CD62L+ subset is a more potent suppressor than the CD62L- population or unfractionated CD4+ CD25+ Treg cells, can be expanded far more easily in culture, and is more responsive to chemokine-driven migration to secondary lymphoid organs. These properties may have significant implications for the clinical manipulation of the CD4+ CD25+ CD62L+ cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14678036     DOI: 10.1046/j.1600-6143.2003.00293.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  56 in total

1.  Natural Tregs, CD4+CD25+ inhibitory hybridomas, and their cell contact dependent suppression.

Authors:  Elizabeth H Field; Katarina Kulhankova; Mohamed E Nasr
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

2.  Therapeutic benefit of pentostatin in severe IL-10-/- colitis.

Authors:  Jeffrey B Brown; Goo Lee; Gery R Grimm; Terrence A Barrett
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

Review 3.  MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development.

Authors:  Katie Podshivalova; Daniel R Salomon
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

Review 4.  Epigenetic mechanisms of regulation of Foxp3 expression.

Authors:  Girdhari Lal; Jonathan S Bromberg
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113

5.  The role of CD4 T cells in the pathogenesis of murine AIDS.

Authors:  Wen Li; William R Green
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Effects of oral commensal and pathogenic bacteria on human dendritic cells.

Authors:  T Chino; D M Santer; D Giordano; C Chen; C Li; C-H Chen; R P Darveau; E A Clark
Journal:  Oral Microbiol Immunol       Date:  2009-04

7.  The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model.

Authors:  Kritika Kachapati; David E Adams; Yuehong Wu; Charles A Steward; Daniel B Rainbow; Linda S Wicker; Robert S Mittler; William M Ridgway
Journal:  J Immunol       Date:  2012-10-12       Impact factor: 5.422

8.  Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway.

Authors:  Sandra Hubert; Björn Rissiek; Katjana Klages; Jochen Huehn; Tim Sparwasser; Friedrich Haag; Friedrich Koch-Nolte; Olivier Boyer; Michel Seman; Sahil Adriouch
Journal:  J Exp Med       Date:  2010-10-25       Impact factor: 14.307

9.  Manipulating IL-2 availability amid presentation of donor MHC antigens suppresses murine alloimmune responses by inducing regulatory T cells.

Authors:  Shuzi Zhang; Hehua Dai; Ni Wan; Yolonda Moore; Zhenhua Dai
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

10.  Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection.

Authors:  Vanessa Oliveira; Birgit Sawitzki; Stephanie Chapman; Christine Appelt; Inga Gebuhr; Joanna Wieckiewicz; Elaine Long; Kathryn J Wood
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.